vs

Side-by-side financial comparison of Mastech Digital, Inc. (MHH) and RECURSION PHARMACEUTICALS, INC. (RXRX). Click either name above to swap in a different company.

Mastech Digital, Inc. is the larger business by last-quarter revenue ($45.5M vs $35.5M, roughly 1.3× RECURSION PHARMACEUTICALS, INC.). Mastech Digital, Inc. runs the higher net margin — 2.1% vs -304.2%, a 306.4% gap on every dollar of revenue. On growth, RECURSION PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (681.7% vs -10.4%). Mastech Digital, Inc. produced more free cash flow last quarter ($4.3M vs $-47.3M). Over the past eight quarters, RECURSION PHARMACEUTICALS, INC.'s revenue compounded faster (60.5% CAGR vs -1.5%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines artificial intelligence and large-scale high-throughput biological experimentation to discover and develop innovative therapies for rare diseases, oncology, inflammatory disorders, and other areas of unmet medical need. It primarily operates in North America and partners with global biopharmaceutical firms to advance its robust therapeutic pipeline.

MHH vs RXRX — Head-to-Head

Bigger by revenue
MHH
MHH
1.3× larger
MHH
$45.5M
$35.5M
RXRX
Growing faster (revenue YoY)
RXRX
RXRX
+692.2% gap
RXRX
681.7%
-10.4%
MHH
Higher net margin
MHH
MHH
306.4% more per $
MHH
2.1%
-304.2%
RXRX
More free cash flow
MHH
MHH
$51.6M more FCF
MHH
$4.3M
$-47.3M
RXRX
Faster 2-yr revenue CAGR
RXRX
RXRX
Annualised
RXRX
60.5%
-1.5%
MHH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MHH
MHH
RXRX
RXRX
Revenue
$45.5M
$35.5M
Net Profit
$972.0K
$-108.1M
Gross Margin
28.3%
59.8%
Operating Margin
2.2%
-304.8%
Net Margin
2.1%
-304.2%
Revenue YoY
-10.4%
681.7%
Net Profit YoY
227.3%
39.6%
EPS (diluted)
$0.08
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MHH
MHH
RXRX
RXRX
Q4 25
$45.5M
$35.5M
Q3 25
$48.5M
$5.2M
Q2 25
$49.1M
$19.2M
Q1 25
$48.3M
$14.7M
Q4 24
$50.7M
$4.5M
Q3 24
$51.8M
$26.1M
Q2 24
$49.5M
$14.4M
Q1 24
$46.8M
$13.8M
Net Profit
MHH
MHH
RXRX
RXRX
Q4 25
$972.0K
$-108.1M
Q3 25
$941.0K
$-162.3M
Q2 25
$135.0K
$-171.9M
Q1 25
$-1.4M
$-202.5M
Q4 24
$297.0K
$-178.9M
Q3 24
$1.9M
$-95.8M
Q2 24
$1.4M
$-97.5M
Q1 24
$-161.0K
$-91.4M
Gross Margin
MHH
MHH
RXRX
RXRX
Q4 25
28.3%
59.8%
Q3 25
27.8%
-183.8%
Q2 25
28.1%
-4.9%
Q1 25
26.7%
-48.0%
Q4 24
29.0%
-181.4%
Q3 24
28.5%
53.7%
Q2 24
28.2%
36.2%
Q1 24
25.9%
19.1%
Operating Margin
MHH
MHH
RXRX
RXRX
Q4 25
2.2%
-304.8%
Q3 25
1.7%
-3327.6%
Q2 25
0.1%
-916.8%
Q1 25
-3.8%
-1297.9%
Q4 24
0.1%
-4042.4%
Q3 24
4.7%
-377.1%
Q2 24
3.4%
-697.4%
Q1 24
-0.9%
-698.4%
Net Margin
MHH
MHH
RXRX
RXRX
Q4 25
2.1%
-304.2%
Q3 25
1.9%
-3135.3%
Q2 25
0.3%
-894.2%
Q1 25
-3.0%
-1373.3%
Q4 24
0.6%
-3935.5%
Q3 24
3.6%
-367.5%
Q2 24
2.8%
-676.6%
Q1 24
-0.3%
-662.4%
EPS (diluted)
MHH
MHH
RXRX
RXRX
Q4 25
$0.08
$-0.17
Q3 25
$0.08
$-0.36
Q2 25
$0.01
$-0.41
Q1 25
$-0.12
$-0.50
Q4 24
$0.01
$-0.56
Q3 24
$0.16
$-0.34
Q2 24
$0.12
$-0.40
Q1 24
$-0.01
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MHH
MHH
RXRX
RXRX
Cash + ST InvestmentsLiquidity on hand
$36.5M
$743.3M
Total DebtLower is stronger
$9.6M
Stockholders' EquityBook value
$89.3M
$1.1B
Total Assets
$111.8M
$1.5B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MHH
MHH
RXRX
RXRX
Q4 25
$36.5M
$743.3M
Q3 25
$32.7M
$659.8M
Q2 25
$27.9M
$525.1M
Q1 25
$24.7M
$500.5M
Q4 24
$27.7M
$594.4M
Q3 24
$23.9M
$427.6M
Q2 24
$20.6M
$474.3M
Q1 24
$19.4M
$296.3M
Total Debt
MHH
MHH
RXRX
RXRX
Q4 25
$9.6M
Q3 25
$11.9M
Q2 25
$14.2M
Q1 25
$16.4M
Q4 24
$19.0M
Q3 24
$20.5M
Q2 24
$22.9M
Q1 24
Stockholders' Equity
MHH
MHH
RXRX
RXRX
Q4 25
$89.3M
$1.1B
Q3 25
$88.0M
$1.0B
Q2 25
$87.8M
$919.1M
Q1 25
$86.9M
$933.9M
Q4 24
$87.4M
$1.0B
Q3 24
$86.5M
$524.6M
Q2 24
$84.0M
$584.4M
Q1 24
$81.7M
$401.2M
Total Assets
MHH
MHH
RXRX
RXRX
Q4 25
$111.8M
$1.5B
Q3 25
$112.6M
$1.4B
Q2 25
$110.4M
$1.3B
Q1 25
$110.1M
$1.3B
Q4 24
$111.5M
$1.4B
Q3 24
$111.5M
$726.5M
Q2 24
$107.5M
$775.9M
Q1 24
$106.1M
$557.8M
Debt / Equity
MHH
MHH
RXRX
RXRX
Q4 25
0.01×
Q3 25
0.01×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.04×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MHH
MHH
RXRX
RXRX
Operating Cash FlowLast quarter
$4.4M
$-46.1M
Free Cash FlowOCF − Capex
$4.3M
$-47.3M
FCF MarginFCF / Revenue
9.5%
-133.1%
Capex IntensityCapex / Revenue
0.1%
3.5%
Cash ConversionOCF / Net Profit
4.48×
TTM Free Cash FlowTrailing 4 quarters
$10.8M
$-378.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MHH
MHH
RXRX
RXRX
Q4 25
$4.4M
$-46.1M
Q3 25
$6.5M
$-117.4M
Q2 25
$3.3M
$-76.4M
Q1 25
$-3.0M
$-132.0M
Q4 24
$4.0M
$-115.4M
Q3 24
$3.3M
$-59.2M
Q2 24
$1.2M
$-82.2M
Q1 24
$-1.3M
$-102.3M
Free Cash Flow
MHH
MHH
RXRX
RXRX
Q4 25
$4.3M
$-47.3M
Q3 25
$6.3M
$-117.6M
Q2 25
$3.2M
$-79.6M
Q1 25
$-3.1M
$-133.8M
Q4 24
$3.9M
$-116.7M
Q3 24
$3.2M
$-63.8M
Q2 24
$707.0K
$-83.4M
Q1 24
$-1.6M
$-109.0M
FCF Margin
MHH
MHH
RXRX
RXRX
Q4 25
9.5%
-133.1%
Q3 25
13.0%
-2272.5%
Q2 25
6.6%
-413.9%
Q1 25
-6.4%
-907.4%
Q4 24
7.7%
-2567.7%
Q3 24
6.2%
-244.6%
Q2 24
1.4%
-578.5%
Q1 24
-3.4%
-789.9%
Capex Intensity
MHH
MHH
RXRX
RXRX
Q4 25
0.1%
3.5%
Q3 25
0.4%
4.7%
Q2 25
0.1%
16.4%
Q1 25
0.2%
12.4%
Q4 24
0.2%
28.6%
Q3 24
0.1%
17.5%
Q2 24
1.0%
8.2%
Q1 24
0.6%
48.2%
Cash Conversion
MHH
MHH
RXRX
RXRX
Q4 25
4.48×
Q3 25
6.88×
Q2 25
24.41×
Q1 25
Q4 24
13.60×
Q3 24
1.76×
Q2 24
0.85×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MHH
MHH

IT Staffing Services$37.6M83%
Data And Analytics Services$7.8M17%

RXRX
RXRX

Segment breakdown not available.

Related Comparisons